← SEMTECH CORP
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net loss | $54.7m | $36.4m | $63.1m | $31.9m | $59.9m | $125.6m | $61.4m | ($1.1b) | ($161.9m) | ($40.4m) | — | |
| Depreciation and amortization | $47.1m | $49.0m | $49.6m | $39.6m | $31.9m | $30.9m | $32.2m | $78.0m | $43.5m | $40.8m | $45.5m | |
| Amortization of right-of-use assets | — | — | $0 | $4.0m | $4.0m | $4.4m | $4.7m | $6.5m | $5.9m | $5.5m | — | |
| Amortization of inventory step-up | — | — | — | — | — | $0 | $0 | $3.3m | $0 | $0 | — | |
| Deferred income taxes | $2.2m | $15.2m | ($16.5m) | ($5.6m) | ($7.4m) | ($3.8m) | ($15.3m) | $40.6m | ($21.7m) | $7.9m | $7.3m | |
| Share-based compensation | $30.8m | $47.9m | $73.9m | $52.0m | $53.0m | $51.2m | $39.2m | $40.2m | $68.0m | $57.7m | $77.3m | |
| Payments for employee share-based compensation payroll taxes | ($6.6m) | ($11.7m) | ($18.5m) | ($21.5m) | ($21.5m) | ($19.4m) | ($14.2m) | ($6.7m) | ($14.0m) | ($27.3m) | — | |
| Right-of-use asset impairment | — | — | — | — | — | $0 | $0 | $3.9m | $0 | $0 | — | |
| Investment impairments and credit loss reserves, net | $0 | $4.2m | $30.0m | $1.2m | $6.8m | $1.3m | $1.2m | $3.9m | $1.1m | $10.4m | — | |
| Impairment of goodwill | — | — | — | — | — | $0 | $0 | $755.6m | $7.5m | $84.8m | — | |
| Intangible impairment | $0 | — | — | — | — | $0 | $0 | $131.4m | $0 | $1.8m | — | |
| Equity in net (gains) losses of equity method investments | $0 | $254k | $126k | ($109k) | ($329k) | ($2.1m) | ($249k) | ($45k) | $547k | ($636k) | — | |
| Accounts receivable, net | ($7.4m) | ($1.5m) | ($21.5m) | $17.3m | ($8.5m) | ($1.1m) | $2.4m | $27.4m | ($28.3m) | $3.3m | ($7.6m) | |
| Inventories | ($2.0m) | ($5.5m) | $8.4m | ($9.3m) | ($14.5m) | ($26.5m) | ($3.8m) | $57.3m | ($18.7m) | ($30.7m) | ($31.2m) | |
| Accounts payable | $3.1m | ($5.3m) | $7.5m | $2.6m | $3.6m | ($2.1m) | ($3.7m) | ($44.3m) | $14.7m | $22.5m | $20.8m | |
| Capital expenditures in accounts payable | $3.4m | $3.8m | $2.0m | ($2.2m) | $2.9m | $5.5m | $9.4m | $860k | $183k | $2.4m | ($27.1m) | |
| Accrued liabilities | $10.6m | $2.5m | ($1.9m) | ($19.5m) | $2.3m | $17.8m | $18.9m | ($118.5m) | ($4.6m) | $5.0m | $6.8m | |
| Accrued deferred financing costs | — | — | — | — | — | $0 | $2.8m | $828k | $0 | $0 | — | |
| Accrued purchase of intangibles | — | — | — | — | — | — | $0 | $0 | $1.6m | $2.2m | — | |
| Other assets | ($7.5m) | ($6.0m) | ($587k) | $2.4m | ($15.1m) | $11.2m | $6.3m | $1.8m | $3.1m | ($12.0m) | — | |
| Other liabilities | $4.2m | ($12.2m) | ($825k) | $3.6m | ($3.7m) | ($8.9m) | ($643k) | ($5.5m) | ($16.0m) | ($5.1m) | — | |
| Net cash provided by (used in) operating activities | $117.6m |
$111.5m
-5.21%
|
$183.6m
+64.65%
|
$118.6m
-35.38%
|
$118.9m
+0.26%
|
$203.1m
+70.79%
|
$126.7m
-37.62%
|
($93.9m)
-174.12%
|
$58.0m
+161.74%
|
$181.2m
+212.43%
|
$189.5m
+4.61%
|
|
| Proceeds from sales of property, plant and equipment | $48k | $189k | $112k | $352k | $385k | $110k | $38k | $410k | $97k | $8k | — | |
| Purchase of property, plant and equipment | ($32.9m) | ($35.5m) | ($17.1m) | ($23.1m) | ($32.7m) | ($26.2m) | ($28.3m) | ($29.2m) | ($7.9m) | ($9.8m) | — | |
| Gain from sale of investments | $0 | ($4.3m) | ($1.3m) | $0 | $0 | — | $0 | $0 | ($277k) | $0 | — | |
| Proceeds from sale of investments | $555k | $0 | $6.0m | $0 | $378k | $0 | $2.3m | $0 | $2.6m | $1.9m | $1.5m | |
| Purchase of investments | ($13.2m) | ($18.7m) | ($9.3m) | ($11.6m) | ($10.9m) | ($8.2m) | ($6.7m) | ($930k) | ($434k) | $0 | $0 | |
| Net cash used in investing activities | ($13.5m) | ($65.9m) | ($36.2m) | ($34.3m) | ($42.9m) | ($40.3m) | ($1.2b) | ($22.7m) | ($11.9m) | ($38.8m) | ($76.2m) | |
| Accretion of deferred financing costs and debt discount | $621k | $568k | $528k | $484k | $482k | $481k | $1.4m | $7.3m | $8.3m | $4.8m | — | |
| Write-off of deferred financing cost and debt discount | $549k | $0 | $0 | $514k | $0 | $0 | $0 | $4.4m | $13.2m | $2.4m | — | |
| Loss on extinguishment of debt | — | — | — | — | — | — | $0 | $0 | $143.5m | $0 | — | |
| Debt extinguished in exchange for common stock | — | — | — | — | — | — | $0 | $0 | $188.1m | $0 | — | |
| Proceeds from issuance of common stock, net of issuance costs | — | — | — | — | — | — | $0 | $0 | $640.7m | $0 | $0 | |
| Net cash (used in) provided by financing activities | ($18.8m) |
($34.8m)
-85.59%
|
($143.1m)
-310.87%
|
($103.1m)
+27.99%
|
($100.5m)
+2.55%
|
($152.1m)
-51.41%
|
$1.1b
+807.79%
|
$10.6m
-99.02%
|
($21.7m)
-305.31%
|
($101.1m)
-366.61%
|
— | |
| Net increase (decrease) in cash and cash equivalents | $85.3m | $10.8m | $4.2m | ($18.8m) | ($24.4m) | $10.7m | ($44.1m) | ($106.9m) | $23.2m | $43.4m | — | |
| Cash and cash equivalents at beginning of period | $211.8m | $297.1m | $307.9m | $293.3m | $293.3m | $268.9m | $235.5m | $128.6m | $151.7m | $195.2m | — | |
| Effect of foreign exchange rate changes on cash and cash equivalents | — | — | — | — | — | $0 | $0 | ($858k) | ($1.3m) | $2.1m | — | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Induced conversion expense | — | — | — | — | — | — | — | $0 | $0 | $21.2m | — | |
| Interest rate swap termination | — | — | — | — | — | — | $0 | $0 | ($3.6m) | ($1.1m) | — | |
| Loss (gain) on disposition of business operations and assets | ($25.5m) | $276k | ($26k) | $378k | $61k | ($54k) | ($18.3m) | $8k | $262k | $75k | — | |
| Corporate owned life insurance, net | $770k | $1.6m | ($34k) | $5.6m | $6.5m | $4.8m | $810k | $4.7m | $3.4m | $2.9m | — | |
| Purchase of intangibles | $0 | — | — | — | — | $0 | $0 | ($1.9m) | ($6.3m) | ($6.0m) | ($10.8m) | |
| Acquisition, net of cash acquired | $0 | ($17.6m) | ($15.9m) | $0 | $0 | $0 | ($1.2b) | $0 | $0 | ($21.5m) | — | |
| Proceeds from corporate-owned life insurance | — | — | — | — | $0 | $0 | $5.1m | $8.9m | $4.8m | $0 | — | |
| Premiums paid for corporate-owned life insurance | — | — | — | $0 | $0 | ($6.0m) | ($5.1m) | $0 | ($4.8m) | ($3.4m) | — | |
| Proceeds from revolving line of credit | $97.0m | $0 | $0 | $201.0m | $0 | $20.0m | $10.0m | $70.0m | $68.2m | $0 | — | |
| Payments of revolving line of credit | ($181.0m) | $0 | $0 | ($101.0m) | ($16.0m) | ($28.0m) | ($33.0m) | ($5.0m) | ($283.2m) | $0 | — | |
| Payments of term loans | ($80.9m) | ($15.0m) | ($15.9m) | ($115.3m) | $0 | $0 | $0 | ($272.4m) | ($441.4m) | ($181.2m) | — | |
| Proceeds from convertible senior notes | — | — | — | — | $0 | $0 | $319.5m | $250.0m | $0 | $402.5m | — | |
| Payments of convertible senior notes | — | — | — | — | — | — | — | $0 | $0 | ($280.9m) | — | |
| Repurchase of warrants | — | — | — | — | — | — | — | $0 | $0 | ($217.8m) | — | |
| Proceeds from unwind of convertible note hedge | — | — | — | — | — | — | — | $0 | $0 | $242.3m | — | |
| Purchase of capped calls | — | — | — | — | — | — | — | $0 | $0 | ($31.4m) | — | |
| Proceeds from interest rate swap termination | — | — | — | — | — | — | $0 | $0 | $4.8m | $295k | — | |
| Deferred financing costs | ($2.1m) | $0 | $0 | ($2.1m) | ($30k) | $0 | ($21.8m) | ($25.4m) | ($824k) | ($11.7m) | — | |
| Proceeds from exercise of stock options | $5.8m | $6.7m | $16.3m | $6.0m | $8.5m | $5.3m | $620k | $0 | $4.3m | $4.2m | — | |
| Distributions to noncontrolling interest | — | — | — | — | — | — | $0 | $0 | ($184k) | $0 | — | |
| Interest paid | $6.5m | $6.3m | $8.6m | $7.9m | $4.9m | $4.3m | $11.7m | $83.6m | $72.5m | $16.3m | $13.1m | |
| Income taxes paid | $10.5m | $31.0m | $7.7m | $11.2m | $8.4m | $3.3m | $10.4m | $19.8m | $8.0m | $4.1m | — | |
| Conversion of note into equity | $1.4m | $0 | $500k | $0 | $0 | $626k | $0 | $1.3m | $0 | $0 | — | |
| Write-off of deferred financing costs pursuant to induced conversion | — | — | — | — | — | — | — | $0 | $0 | $4.6m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.